Concepedia

Mirko Rivara

MR

Statistics

Publications

21

Citations

934

H-Index

18

Active since

2003

Affiliations

University of Parma(Current)

Siena Biotech (Italy)

University of Virginia

University of Virginia Health System

University of Milan

Mirko Rivara is an author at University of Parma specializing in medicinal chemistry, pharmacology, and medicine.

ORCID

Publications per year

2003–2022

21

Publications

21

Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release

Aristos J. Alexandrou, Adam R. Brown, Mark L. Chapman et al. · PLoS ONE · 2016 · 194 citations · Full text

, , +17

3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line

Alessio Malacrida, Mirko Rivara, Alessandro Di Domizio et al. · Bioorganic & Medicinal Chemistry · 2019 · 190 citations

, , +9

A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks

Valentina Zuliani, Giuseppe Cocconcelli, Marco Fantini et al. · The Journal of Organic Chemistry · 2007 · 61 citations

, , +14

5-Benzylidene-hydantoins: Synthesis and antiproliferative activity on A549 lung cancer cell line

Valentina Zuliani, Caterina Carmi, Mirko Rivara et al. · European Journal of Medicinal Chemistry · 2009 · 45 citations · Full text

, , +9

Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists

Simone Lorenzi, Marco Mor, Fabrizio Bordi et al. · Bioorganic & Medicinal Chemistry · 2005 · 44 citations

, , +16

1–5 of 21